In this post, we introduce our CMN disease overview, which will provide information on all the diseases that are targeted by gene-editing therapies...
In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...
In this piece, we provide selected highlights from the 63rd American Society of Hematology annual meeting, held from December 11-14th 2021.
CRISPR-based blood cell therapies are advancing through clinical trials, with promising results stacking up for certain rare genetic diseases and some...
In this week’s update, we present a CRISPR-based therapy for sickle cell disease that has moved from the investigational new drug (IND) stage into a...
